Nanotechnology, Cancer, Health Technology, Medical Technology, Innovation.
must be considered when calculating the optimal number of binding sites on a nanocarrier. A nanocarrier with more of those targeting molecules might find and bind to many of the corresponding biomarkers at once. While such a configuration is stable, it can decrease the nanocarrier’s ability to